BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33421239)

  • 1. The advantages, pitfalls and limitations of guideline-directed medical therapy in patients with valvular heart disease.
    Gill H; Chehab O; Allen C; Patterson T; Redwood S; Rajani R; Prendergast B
    Eur J Heart Fail; 2021 Aug; 23(8):1325-1333. PubMed ID: 33421239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous-Flow Left Ventricular Assist Devices and Valvular Heart Disease: A Comprehensive Review.
    Noly PE; Pagani FD; Noiseux N; Stulak JM; Khalpey Z; Carrier M; Maltais S
    Can J Cardiol; 2020 Feb; 36(2):244-260. PubMed ID: 32036866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valvular Heart Disease in Adults: Management of Native Valve Disease.
    Zhang X; Hollenberg SM
    FP Essent; 2017 Jun; 457():17-22. PubMed ID: 28671805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of intervention in asymptomatic patients with valvular heart disease.
    Baumgartner H; Iung B; Otto CM
    Eur Heart J; 2020 Dec; 41(45):4349-4356. PubMed ID: 32901279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience.
    Nader V; Matta A; Canitrot R; Itier R; Salameh P; Lairez O; Elbaz M; Galinier M; Azar R; Roncalli J
    Med Sci Monit; 2021 Feb; 27():e928218. PubMed ID: 33558450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of hospitalized patients with valvular heart disease: Experience of a tertiary center.
    Esteves AF; Brito D; Rigueira J; Ricardo I; Pires R; Pedro MM; Veiga F; Pinto F
    Rev Port Cardiol (Engl Ed); 2018 Dec; 37(12):991-998. PubMed ID: 30554887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valvular heart disease in Japan: Characteristics and treatment of patients in acute care hospitals in 2019.
    Izumi C; Matsuyama R; Asaoka M; Iwasaki K; Takeshima T; Murphy S; Teng L; Igarashi A
    J Cardiol; 2023 Jul; 82(1):29-34. PubMed ID: 36963659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Mitral Valve Interventions and Heart Failure.
    Sharma A; Goel S; Agrawal S
    Adv Exp Med Biol; 2018; 1067():271-285. PubMed ID: 29277857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Choice of Treatment in Ischemic Mitral Regurgitation With Reduced Left Ventricular Function.
    Nappi F; Avtaar Singh SS; Padala M; Attias D; Nejjari M; Mihos CG; Benedetto U; Michler R
    Ann Thorac Surg; 2019 Dec; 108(6):1901-1912. PubMed ID: 31445916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter Mitral-Valve Repair in Patients with Heart Failure.
    Stone GW; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant B; Grayburn PA; Rinaldi M; Kapadia SR; Rajagopal V; Sarembock IJ; Brieke A; Marx SO; Cohen DJ; Weissman NJ; Mack MJ;
    N Engl J Med; 2018 Dec; 379(24):2307-2318. PubMed ID: 30280640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and Prognosis of Patients With Nonvalvular Atrial Fibrillation and Significant Valvular Heart Disease Referred for Electrical Cardioversion.
    Vo NM; Leung M; van Rosendael PJ; Goedemans L; van Wijngaarden SE; Prihadi EA; van der Bijl P; Ajmone Marsan N; Delgado V; Bax JJ
    Am J Cardiol; 2020 Aug; 128():84-91. PubMed ID: 32650929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valvular Heart Disease in Patients ≥80 Years of Age.
    Kodali SK; Velagapudi P; Hahn RT; Abbott D; Leon MB
    J Am Coll Cardiol; 2018 May; 71(18):2058-2072. PubMed ID: 29724358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valvular Heart Disease Epidemics.
    Domenech B; Pomar JL; Prat-González S; Vidal B; López-Soto A; Castella M; Sitges M
    J Heart Valve Dis; 2016 Jan; 25(1):1-7. PubMed ID: 29505225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study.
    Huang X; Dhruva SS; Yuan X; Bai X; Lu Y; Yan X; Liu J; Li W; Hu D; Ji R; Gao M; Miao F; Li J; Ge J; Krumholz HM; Li J
    BMJ Open; 2021 Nov; 11(11):e052946. PubMed ID: 34732492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
    Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
    Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK.
    Marciniak A; Glover K; Sharma R
    BMJ Open; 2017 Jan; 7(1):e012240. PubMed ID: 28131996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
    Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
    Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.